US Stock MarketDetailed Quotes
BIOAF BIOASIS TECHNOLOGIES INC
- 0.004000
- 0.0000000.00%
15min DelayClose Apr 24 16:00 ET
317.66KMarket Cap-137P/E (TTM)
0.000000High0.000000Low0Volume0.004000Open0.004000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)79.41MShares0.01820052wk High-0.16P/B317.66KFloat Cap0.00150052wk Low--Dividend TTM79.41MShs Float0.339400Historical High--Div YieldTTM0.00%Amplitude0.001500Historical Low--Avg Price1Lot Size
About BIOASIS TECHNOLOGIES INC Company
biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Company Profile
SymbolBIOAF
Company NameBIOASIS TECHNOLOGIES INC
Founded2006
CEOMs. Deborah Ann Rathjen
MarketPink Market
Securities TypeOrdinary Shares
Fiscal Year Ends02-28
Address157 Church Street,19th floor
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06510
Phone1-203-533-7082
Websitehttp://www.bioasis.us
Company Executives
- Name
- Position
- Salary
- Deborah Ann Rathjen
- Executive Chairman of the Board, President and Chief Executive Officer
- --
- Dave Jenkins
- Chief Financial Officer
- --
- Dr. Mei Mei Tian, PhD
- Vice President and Head of External Research
- --
- John Murray Hemeon
- Director
- --
- David M. Wurzer
- Lead Independent Director
- --
- Dr. Mario Saltarelli
- Independent Director
- --
- John E. Curran
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg